Summary Aesica Pharmaceuticals Ltd (Aesica), a subsidiary of Consort Medical plc is a contract development and manufacturing organization (CDMO). It manufactures and develops generic active pharmaceutical ingredients (APIs) and finished dosage forms. Aesica’s services portfolio encompass pre-formulation, formulation, development and manufacturing services, analysis and stability testing, manufacture of clinical trial materials, packaging and labelling of dosage forms, regulatory support and technology transfer. The company has manufacturing facilities in the UK, Germany and Italy; and an international office in Shanghai, China. Aesica is headquartered in Newcastle upon Tyne, Tyne and Wear, the UK. Aesica Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile. provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. GlobalData derived the data... Research Beam Model: Research Beam Product ID: 1746996 250 USD New
Aesica Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile.
 
 

Aesica Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile.

  • Category : Pharmaceuticals
  • Published On : July   2017
  • Pages : 21
  • Publisher : GlobalData
 
 
 
Summary

Aesica Pharmaceuticals Ltd (Aesica), a subsidiary of Consort Medical plc is a contract development and manufacturing organization (CDMO). It manufactures and develops generic active pharmaceutical ingredients (APIs) and finished dosage forms. Aesica’s services portfolio encompass pre-formulation, formulation, development and manufacturing services, analysis and stability testing, manufacture of clinical trial materials, packaging and labelling of dosage forms, regulatory support and technology transfer. The company has manufacturing facilities in the UK, Germany and Italy; and an international office in Shanghai, China. Aesica is headquartered in Newcastle upon Tyne, Tyne and Wear, the UK.

Aesica Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile. provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Aesica Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 4
Aesica Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Aesica Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Aesica Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Aesica Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Aesica Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Aesica Pharma Acquires Three Manufacturing Sites From UCB 10
Private Equity 11
Silverfleet Capital Completes Acquisition Of Majority Stake In Aesica Pharma From LDC 11
Partnerships 12
QrxPharma Enters Into Agreement With Aesica Formulation For Stealth Beadlets Abuse Deterrence Technology 12
Aesica Enters Into Co-Development Agreement With University Of Nottingham For Amide Bond Synthesis 13
Aesica Pharmaceuticals Ltd - Key Competitors 15
Key Employees 16
Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Strategy And Business Planning 18
Apr 06, 2016: Aesica Adds Development Capability At Queenborough With Opening Of New Purpose Built Facility 18
Other Significant Developments 19
May 16, 2016: Aesica Meets The Serialization Challenge – Novel Modular Solution Complies With All The World’s Differing Regulations 19
Jan 19, 2016: Strategic Relocation Of Development And Clinical Manufacturing Services From Nottingham To Queenborough Is Now Complete 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Aesica Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 1
Aesica Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Aesica Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Aesica Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Aesica Pharmaceuticals Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Aesica Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Aesica Pharma Acquires Three Manufacturing Sites From UCB 10
Silverfleet Capital Completes Acquisition Of Majority Stake In Aesica Pharma From LDC 11
QrxPharma Enters Into Agreement With Aesica Formulation For Stealth Beadlets Abuse Deterrence Technology 12
Aesica Enters Into Co-Development Agreement With University Of Nottingham For Amide Bond Synthesis 13
Aesica Pharmaceuticals Ltd, Key Competitors 15
Aesica Pharmaceuticals Ltd, Key Employees 16
Aesica Pharmaceuticals Ltd, Other Locations 17
Aesica Pharmaceuticals Ltd, Subsidiaries 17
List of Figures
Aesica Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Aesica Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Aesica Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Aesica Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Aesica Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Aesica Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Aesica Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Aesica Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter